Alembic Pharmaceuticals rises on getting USFDA’s final nod for Doxycycline Hyclate Delayed release tablets
Alembic Pharmaceuticals is currently trading at Rs. 812.00, up by 2.40 points or 0.30% from its previous closing of Rs. 809.60 on the BSE. The…